Cargando…
A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder
Major depressive disorder (MDD) is the most prevalent form of depression and is becoming a great challenge for public health and medical practice. Although first-line antidepressants offer therapeutic benefits, about 35% of depressed patients are not adequately treated, creating a substantial unmet...
Autores principales: | Mi, Weifeng, Di, Xiaolan, Wang, Yiming, Li, Huafang, Xu, Xiufeng, Li, Lehua, Wang, Huaning, Wang, Guoqiang, Zhang, Kerang, Tian, Feng, Luo, Jiong, Yang, Chanjuan, Zhou, Yunfei, Xie, Shiping, Zhong, Hua, Wu, Bin, Yang, Dong, Chen, Zhenhua, Li, Yi, Chen, Jindong, Lv, Shuyun, Yi, Qizhong, Jiang, Zhiwei, Tian, Jingwei, Zhang, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171157/ https://www.ncbi.nlm.nih.gov/pubmed/37164957 http://dx.doi.org/10.1038/s41398-023-02435-0 |
Ejemplares similares
-
Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial
por: Mi, Weifeng, et al.
Publicado: (2021) -
Verifying Negative Sentences
por: Wang, Shenshen, et al.
Publicado: (2021) -
RPdb: a database of experimentally verified cellular reprogramming records
por: Shen, Yi, et al.
Publicado: (2015) -
Treatment of major depressive disorders with generic
duloxetine and paroxetine: a multi-centered, double-blind,
double-dummy, randomized controlled clinical trial
por: WANG, Zhiyang, et al.
Publicado: (2015) -
Towards a Formally Verified EVM in Production Environment
por: Zhang, Xiyue, et al.
Publicado: (2020)